Dar Dowlatshahi Selected Research

CDTA (DCTA)

11/2020	Prevalence and the predictive performance of the dynamic CT-angiography spot sign in an observational cohort with intracerebral hemorrhage.
1/2020	Distribution and predictive performance of the temporal phase of dynamic spot sign appearance in acute intracerebral hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dar Dowlatshahi Research Topics

Disease

57	Stroke (Strokes) 06/2022 - 11/2006
21	Ischemic Stroke 01/2022 - 01/2013
20	Cerebral Hemorrhage 01/2022 - 06/2012
15	Hemorrhage 01/2022 - 06/2012
13	Hematoma 01/2022 - 05/2009
7	Atrial Fibrillation 01/2022 - 09/2013
7	Thrombosis (Thrombus) 01/2022 - 01/2018
5	Transient Ischemic Attack 01/2022 - 11/2010
5	Infarction (Infarctions) 01/2021 - 03/2016
4	Pain (Aches) 01/2021 - 01/2016
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 07/2012
3	Hypertension (High Blood Pressure) 01/2022 - 11/2006
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2022 - 11/2018
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2018
2	Coma (Comas) 01/2022 - 12/2015
2	Venous Thromboembolism 01/2021 - 11/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2019
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 11/2019
2	Intracranial Thrombosis (Cerebral Thrombosis) 03/2020 - 11/2018
1	Hemorrhagic Stroke 01/2022
1	Hypertriglyceridemia 01/2022
1	Embolic Stroke 01/2022
1	Patent Foramen Ovale 01/2022
1	Prediabetic State (Prediabetes) 05/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Cognitive Dysfunction 01/2021
1	Insulin Resistance 01/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Disease Progression 11/2020
1	Paresis (Hemiparesis) 10/2020
1	Fever (Fevers) 01/2020
1	Leukoaraiosis 01/2019
1	Ischemia 01/2019
1	Cerebral Infarction 01/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2018
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2018
1	Carotid Artery Diseases 01/2018
1	Migraine Disorders (Migraine) 05/2017

Drug/Important Bio-Agent (IBA)

18	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 06/2013
17	AnticoagulantsIBA 01/2022 - 07/2012
7	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 11/2010
6	Hemostatics (Antihemorrhagics)IBA 01/2021 - 07/2012
5	TabletsIBA 01/2019 - 01/2016
4	Vitamin K FDA Link 01/2019 - 11/2015
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2020
3	Tenecteplase FDA Link 01/2022 - 03/2015
3	recombinant FVIIa (rFVIIa)FDA Link 01/2022 - 12/2019
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2020
3	Dabigatran FDA Link 01/2020 - 09/2013
2	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2021
2	TicagrelorIBA 01/2022 - 01/2021
2	CDTA (DCTA)IBA 11/2020 - 01/2020
2	prothrombin complex concentrates (PPSB)IBA 11/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2018
2	RivaroxabanIBA 01/2019 - 09/2013
2	apixabanIBA 01/2019 - 09/2013
2	N(4)-oleylcytosine arabinosideIBA 11/2018 - 05/2017
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2018 - 03/2015
2	Pharmaceutical PreparationsIBA 03/2015 - 09/2013
2	FibrinIBA 03/2015 - 01/2014
1	Heparinoids (Heparinoid)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Factor VIIa (Activated Factor VII)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	C-Reactive ProteinIBA 05/2021
1	hydroxyethyl methacrylate (HEMA)IBA 03/2021
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2021
1	Tranexamic Acid (AMCA)FDA Link 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Nicardipine (Dagan)FDA LinkGeneric 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Factor VII (Proconvertin)IBA 12/2019
1	edoxabanIBA 01/2019
1	Cytidine Triphosphate (CTP)IBA 01/2019
1	boldenone undecylenate (Equipoise)IBA 11/2018
1	N 30IBA 05/2018
1	Pain-FreeIBA 05/2017
1	Milrinone (Primacor)FDA LinkGeneric 01/2017

Therapy/Procedure

30	Therapeutics 01/2022 - 01/2013
8	Thrombectomy 01/2021 - 06/2016
5	Secondary Prevention 06/2022 - 11/2006
5	Stents 10/2018 - 09/2014
3	Stroke Rehabilitation 01/2019 - 01/2016
2	Endarterectomy (Thromboendarterectomy) 01/2021 - 11/2019
2	Length of Stay 01/2021 - 01/2020
2	Continuity of Patient Care 01/2021 - 01/2020
2	Carotid Endarterectomy 11/2020 - 09/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Activities of Daily Living (ADL) 10/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Drug Therapy (Chemotherapy) 11/2018
1	Decompression 01/2018
1	Erythrocyte Transfusion 01/2017